focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Poor - The "buys" you are posting may not all be buys is what he's trying to say.
I for one have seen a purchase I've made listed as a sell - this is due to the price I bought at being below the middle ground between bid and ask.
I see little value in all the buys - they could all be sells that are lower than middle ground in fact pushing the price further down.
12/10/20 17:10 240,000 33.77 0.00 0.00 £81,036.00 Buy
12/10/20 17:08 296,900 33.75 0.00 0.00 £100,203.75 Buy
12/10/20 16:45 200,000 33.11 33.00 34.50 £66,222.20 Sell
Big boys are at play again after close...
Food for thought for what's occuring in the next 3 months:
Q4 2020 PIPELINE
- 3x Foralumab trials start
- main market move
- mid-analysis phase II readout in Foralumab nasal
- Full phase II readout Covid-19 trial
- IL-6 IND Submission
- Update on patents for various mAb treatments
- Milciclib p3
- 2x FDA responses. Due mid Oct.
GLA.
Hi all,
Relatively new here. I bought in mid last week and been topping up since.
I've done quite a bit of reading up on EUA however can't for the life of me find a reason as to why SP dropped for a month post the 25 Aug update stating the flanks application was approved by SevZapNedra. I would have expected a slow and steady rise till sale.
Any ideas or anything I may have missed?
Thanks in advance